Acquired resistance to osimertinib in advanced lung cancer: A case report.

Asian J Surg

Department of Respiratory and Critical Care Medicine, Affiliated Hospital of Nantong University, Nantong, 226001, China. Electronic address:

Published: August 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.asjsur.2024.04.116DOI Listing

Publication Analysis

Top Keywords

acquired resistance
4
resistance osimertinib
4
osimertinib advanced
4
advanced lung
4
lung cancer
4
cancer case
4
case report
4
acquired
1
osimertinib
1
advanced
1

Similar Publications

Background: Programmed cell death 1 (PD-1) signaling blockade by immune checkpoint inhibitors (ICI) effectively restores immune surveillance to treat melanoma. However, chronic interferon-gamma (IFNγ)-induced immune homeostatic responses in melanoma cells contribute to immune evasion and acquired resistance to ICI. Poly ADP ribosyl polymerase 14 (PARP14), an IFNγ-responsive gene product, partially mediates IFNγ-driven resistance.

View Article and Find Full Text PDF

Emergence of a novel group B streptococcus CC61 clade associated with human infections in southern China.

J Infect

January 2025

National Key Laboratory of Agricultural Microbiology, College of Fisheries, Huazhong Agricultural University, Wuhan, PR China; Hubei Hongshan Laboratory, Wuhan, PR China; Engineering Research Center of Green Development for Conventional Aquatic Biological Industry in the Yangtze River Economic Belt, Ministry of Education, Wuhan, PR China. Electronic address:

Objectives: Emerging human pathogens of animal origin have become an increasing public health concern in recent years. The aim of this study was to investigate the transmission of group B streptococcus (GBS) clonal complex (CC) 61 strains in the southern Chinese population and analyze their genetic characteristics.

Methods: Whole-genome sequencing was performed on 693 clinical isolates of GBS collected from southern China between 2016 and 2021, and the prevalence of human CC61 isolates was investigated by genomic epidemiology.

View Article and Find Full Text PDF

Selective pressure of various levels of erythromycin on the development of antibiotic resistance.

Environ Pollut

January 2025

Civil and Construction Engineering and Environmental and Ecological Engineering, Purdue University, 550 Stadium Mall Drive, West Lafayette, Indiana, United States 47907. Electronic address:

This study evaluated microbial fitness under selective pressure of various erythromycin concentrations and the development of resistance genes in Escherichia coli (E. coli) and Enterococcus faecalis (E. faecalis).

View Article and Find Full Text PDF

Highly Optimized CNS Penetrant Inhibitors of EGFR Exon20 Insertion Mutations.

J Med Chem

January 2025

Pharmaron Beijing Co., Ltd., 6 Taihe Road, BDA, Beijing 100176, P. R. China.

Despite recent advances in the inhibition of EGFR (epidermal growth factor receptor), there remains a clinical need for new EGFR Exon20 insertion (Ex20Ins) inhibitors that spare EGFR WT. Herein, we report the discovery and optimization of two chemical series leading to ether and biaryl as potent, selective, and brain-penetrant inhibitors of Ex20Ins mutants. Building on our earlier discovery of alkyne which allowed access to CNS property space for an Ex20Ins inhibitor, we utilized structure-based design to move to lower lipophilicity and lower CL compounds while maintaining a WT selectivity margin.

View Article and Find Full Text PDF

In critically ill patients, the occurrence of multidrug-resistant infection is a significant concern, given its ability to acquire multidrug-resistant, form biofilms and secrete toxic effectors. In Brazil, limited data are available regarding the prevalence of dissemination, and the impact of the type III secretion system (T3SS) on toxin production and biofilm formation in clinical isolates of . This study investigates the dissemination of virulent harbouring the and genes, the presence of T3SS genes and their biofilm-forming capability.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!